Quantcast
Last updated on April 24, 2014 at 5:01 EDT

Victhom Announces Launch of Enhanced Company Website

January 9, 2009

QUEBEC, Jan. 9 /PRNewswire-FirstCall/ – Victhom Human Bionics Inc., “Victhom” (TSX: VHB), today announced the unveiling of its updated corporate Website at www.victhom.com. The Website features a new structure that highlights advances in the Company’s two operating divisions; Neurobionix, which is developing an implantable neurostimulation device for gait disorders, and Biotronix, which is developing and manufacturing computerized prostheses for above-knee amputees.

Commenting on the new Website, Normand Rivard, Acting President and Chief Financial Officer, stated: “The new layout provides users with more intuitive navigation, enhanced visual content and a comprehensive view of the Company’s technologies and products”. He went on to say, “This redesigned Website affirms our commitment to provide relevant information and educate all of our stakeholders including patients, medical professionals, investors, and current and future business partners”.

The Neurobionix division portion of the Website includes a new “Patient section” that provides information on the impact of cerebral stroke and a particular aspect of gait disorder known as foot drop. This section presents contemporary treatment options for foot drop sufferers as well as the emerging use of neurostimulation devices that provide instantaneous assistance to patients.

A new “Medical Professional section” has been added and designed for use by members of the professional medical community. This section provides medical and technical information on the Company’s proprietary implantable assistive device known as Neurostep(R), which is currently in clinical trials and designed to restore mobility to persons suffering from foot drop. Information about the product includes a new animation video demonstrating various aspects of the Neurostep(R) System as well as updates regarding the Company’s clinical activities.

The Biotronix division section highlights the Company’s biomechatronic technology capabilities and specifically the Power Knee, a motorized battery-powered transfemoral prosthesis for above-knee amputees exclusively distributed by our business partner Ossur hf (www.ossur.com).

About Victhom

Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom’s Neurobionix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom’s Biotronix division develops biomechatronic products to support or replace peripheral limbs in what is known as the orthotics and prosthetics market.

FORWARD-LOOKING STATEMENTS

Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause Victhom’s actual results, performance or achievements to be materially different from those expressed or implied by any of Victhom’s statements. Actual events or results may differ materially. We disclaim any intention, and assume no obligation, to update these forward-looking statements.

SOURCE VICTHOM HUMAN BIONICS INC.


Source: newswire